LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 17.28 | 27.76 | 1023 | 838 | 1.2197 | 1.0824 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 17.28 | 27.76 | 98 | 838 | 0.1169 | 0.2924 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 17.28 | 27.76 | 1081 | 838 | 1.2889 | 1.1059 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 18.98 | 27.76 | 9 | 941 | 0.0096 | -0.1987 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 18.98 | 27.76 | 1088 | 941 | 1.1560 | 1.0579 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 18.98 | 27.76 | 155 | 941 | 0.1647 | 0.4026 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 18.98 | 27.76 | 1112 | 941 | 1.1815 | 1.0667 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 20.68 | 27.76 | 6 | 1119 | 0.0054 | -0.2497 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 20.68 | 27.76 | 1137 | 1119 | 1.0161 | 1.0060 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 20.68 | 27.76 | 398 | 1119 | 0.3557 | 0.6476 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 20.68 | 27.76 | 1201 | 1119 | 1.0733 | 1.0267 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 22.39 | 27.76 | 11 | 1305 | 0.0084 | -0.1535 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 22.39 | 27.76 | 1217 | 1305 | 0.9321 | 0.9748 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 22.39 | 27.76 | 697 | 1305 | 0.5338 | 0.7863 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 22.39 | 27.76 | 1268 | 1305 | 0.9711 | 0.9895 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 24.09 | 27.76 | 14 | 1461 | 0.0096 | -0.1128 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 24.09 | 27.76 | 1295 | 1461 | 0.8860 | 0.9581 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 24.09 | 27.76 | 866 | 1461 | 0.5925 | 0.8251 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 24.09 | 27.76 | 1382 | 1461 | 0.9455 | 0.9805 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 25.79 | 27.76 | 17 | 1605 | 0.0106 | -0.0804 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 25.79 | 27.76 | 1363 | 1605 | 0.8492 | 0.9449 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 25.79 | 27.76 | 1235 | 1605 | 0.7694 | 0.9124 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 25.79 | 27.76 | 1467 | 1605 | 0.9139 | 0.9695 | MN20160318_Q01 | E11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 27.49 | 27.76 | 24 | 1723 | 0.0139 | -0.0241 | MN20160318_Q01 | D14 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 27.49 | 27.76 | 1425 | 1723 | 0.8270 | 0.9372 | MN20160318_Q01 | D14 |